Related Experiment Video
Updated: Jul 3, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology
S C Menon1, V V Michels, P A Pellikka
1Department of Pediatric and Adolescent Medicine, Division of Cardiology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Insights
A novel mutation in the cardiac troponin T (TNNT2) gene causes varied heart muscle diseases, including restrictive cardiomyopathy (RCM), hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM), within a single family.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Cardiomyopathy
Background:
- Familial heart disease can present with diverse clinical manifestations.
- Understanding the genetic underpinnings of variable cardiomyopathy phenotypes is crucial for diagnosis and management.
Purpose of the Study:
- To identify the molecular genetic cause of a unique autosomal dominant heart disease exhibiting variable expression.
- To investigate the link between sarcomeric protein gene mutations and divergent cardiac remodeling pathways.
Main Methods:
- Segregation analysis of polymorphic DNA markers for nine known sarcomeric genes.
- Exclusion of linkage to eight genes.
- Sequencing of the cardiac troponin T (TNNT2) gene in affected and unaffected family members.
Main Results:
- A heterozygous missense mutation (I79N) in the TNNT2 gene cosegregated with the heart disease phenotype in the family.
- All nine affected individuals carried the mutation, while six unaffected relatives did not.
- Mutation carriers presented with a spectrum of cardiomyopathies: RCM, HCM, DCM, mixed cardiomyopathy, and left ventricular hypertrophy.
Conclusions:
- A mutation in a sarcomeric protein gene (TNNT2) can lead to diverse cardiomyopathy subtypes (RCM, HCM, DCM) within the same family.
- Comprehensive cardiac assessment is essential for screening familial cardiomyopathies.
- This finding highlights the role of TNNT2 in varied cardiac remodeling.
Abstract:
We identified a unique family with autosomal dominant heart disease variably expressed as restrictive cardiomyopathy (RCM), hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (DCM), and sought to identify the molecular defect that triggered divergent remodeling pathways. Polymorphic DNA markers for nine sarcomeric genes for DCM and/or HCM were tested for segregation with disease. Linkage to eight genes was excluded, but a cardiac troponin T (TNNT2) marker cosegregated with the disease phenotype. Sequencing of TNNT2 identified a heterozygous missense mutation resulting in an I79N substitution, inherited by all nine affected family members but by none of the six unaffected relatives. Mutation carriers were diagnosed with RCM (n = 2), non-obstructive HCM (n = 3), DCM (n = 2), mixed cardiomyopathy (n = 1), and mild concentric left ventricular hypertrophy (n = 1). Endomyocardial biopsy in the proband revealed non-specific fibrosis, myocyte hypertrophy, and no myofibrillar disarray. Restrictive Doppler filling patterns, atrial enlargement, and pulmonary hypertension were observed among family members regardless of cardiomyopathy subtype. Mutation of a sarcomeric protein gene can cause RCM, HCM, and DCM within the same family, underscoring the necessity of comprehensive morphological and physiological cardiac assessment in familial cardiomyopathy screening.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

